Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CAO Alexis Gil II sold 1,962 shares of the firm's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $8.43, for a total transaction of $16,539.66. Following the transaction, the chief accounting officer owned 173,825 shares of the company's stock, valued at approximately $1,465,344.75. This trade represents a 1.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Integral Ad Science Stock Up 0.2%
Shares of IAS stock traded up $0.02 during trading on Wednesday, hitting $8.29. 177,936 shares of the company were exchanged, compared to its average volume of 962,769. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.01 and a current ratio of 4.01. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of 28.57, a P/E/G ratio of 1.43 and a beta of 1.57. The business's 50-day simple moving average is $8.02 and its 200 day simple moving average is $8.84. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.03 by $0.02. The business had revenue of $134.07 million during the quarter, compared to analysts' expectations of $129.20 million. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. As a group, analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on IAS shares. Stifel Nicolaus reduced their price objective on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Raymond James Financial raised their price objective on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Tuesday, May 13th. Morgan Stanley reduced their price objective on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Robert W. Baird reiterated a "neutral" rating and issued a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Finally, Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Six research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $13.55.
Read Our Latest Stock Report on IAS
Institutional Trading of Integral Ad Science
Institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its stake in Integral Ad Science by 547.1% in the first quarter. GAMMA Investing LLC now owns 3,313 shares of the company's stock valued at $270,000 after acquiring an additional 2,801 shares during the last quarter. State of Wyoming acquired a new stake in Integral Ad Science in the fourth quarter valued at approximately $51,000. DekaBank Deutsche Girozentrale acquired a new stake in Integral Ad Science in the first quarter valued at approximately $42,000. Alta Fox Capital Management LLC acquired a new stake in Integral Ad Science in the fourth quarter valued at approximately $61,000. Finally, Virtu Financial LLC acquired a new stake in Integral Ad Science in the first quarter valued at approximately $87,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.
About Integral Ad Science
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.